CD4 and cholangiocarcinoma: Figure 1B demonstrates a significant reduction in circulating CD4+ Treg levels (measured in whole blood) in both CCA and HCC patients, at T0, compared to healthy controls (p < 0.05), with levels recovering post-surgery (T1).